Legend Biotech (LEGN) Gross Margin (2022 - 2026)
Legend Biotech's (LEGN) quarterly Gross Margin came in at 42.51% in Q1 2026, down 2185.0% YoY from 2.04% in Q1 2025, and down 27.22% on a QoQ basis from 58.41% in Q3 2025.
Legend Biotech (LEGN) Gross Margin (2022 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 5 years of Gross Margin data on file, last reported at 42.51% in Q1 2026.
- Quarterly Gross Margin fell 2185.0% year-over-year to 42.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.44% (down 1704.0% YoY) and the FY2024 annual result came in at 65.51%, up 1608.0% from the prior year.
- Gross Margin declined to 42.51% in Q1 2026, from 58.41% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 99.96% in Q4 2023 to a low of 1.99% in Q1 2023.
- A 5-year average of 51.25% and a median of 56.93% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 8306 bps — and 2024, when it tumbled 3717 bps.
- Tracing LEGN's Gross Margin over 5 years: stood at 16.9% in 2022, then jumped by 492 bps to 99.96% in 2023, then plunged by 37 bps to 62.79% in 2024, then retreated by 7 bps to 58.41% in 2025, then decreased by 27 bps to 42.51% in 2026.
- The last three Gross Margin figures came in at 42.51% (Q1 2026), 58.41% (Q3 2025), and 62.8% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 64.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.90% |
| Mar 31, 2026 | 42.51% |
| Sep 30, 2025 | 58.41% |
| Jun 30, 2025 | 62.80% |
| Mar 31, 2025 | 64.36% |
| Dec 31, 2024 | 62.79% |
| Sep 30, 2024 | 67.22% |
| Jun 30, 2024 | 75.68% |
| Mar 31, 2024 | 47.76% |
| Dec 31, 2023 | 99.96% |
| Sep 30, 2023 | 54.72% |
| Jun 30, 2023 | 55.45% |
| Mar 31, 2023 | 1.99% |
| Dec 31, 2022 | 16.90% |
| Sep 30, 2022 | 6.95% |